Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
0.608
-0.014 (-2.25%)
Nov 21, 2024, 2:12 PM EST - Market open
Protagenic Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 4 | 7 | 23 | 11 | 14 | |
| Market Cap Growth | -64.83% | -36.50% | -70.56% | 115.87% | -24.82% | -29.49% | |
| Enterprise Value | 2 | -0 | -1 | 13 | 11 | 14 | |
| Last Close Price | 0.60 | 0.99 | 1.60 | 5.54 | 4.20 | 5.64 | |
| PB Ratio | 3.98 | 1.20 | 1.00 | 2.36 | -9.46 | -22.81 | |
| P/TBV Ratio | 3.90 | 1.20 | 1.00 | 2.36 | - | - | |
| Debt / Equity Ratio | - | - | 0.05 | 0.03 | -1.19 | -0.44 | |
| Quick Ratio | 1.34 | 6.19 | 7.12 | 12.97 | 1.02 | 0.67 | |
| Current Ratio | 1.80 | 6.41 | 7.18 | 13.83 | 1.34 | 0.70 | |
| Return on Equity (ROE) | -231.87% | -94.48% | -42.18% | -102.88% | - | - | |
| Return on Assets (ROA) | -94.91% | -45.78% | -23.29% | -43.35% | -185.27% | -169.42% | |
| Return on Capital (ROIC) | -124.50% | -51.77% | -25.38% | -49.36% | - | - | |
| Earnings Yield | -212.44% | -113.89% | -51.42% | -19.26% | -23.43% | -12.10% | |
| FCF Yield | -174.35% | -87.76% | -28.86% | -11.92% | -12.40% | -3.37% | |
| Buyback Yield / Dilution | -2.87% | -0.62% | -17.17% | -42.57% | -0.76% | - | |
| Total Shareholder Return | -2.87% | -0.62% | -17.17% | -42.57% | -0.76% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.